Table 2 Demographic data for patients with different seizure disorders
From: Epilepsy and other seizure disorders in acute psychiatric inpatients
| Acute symptomatic seizures (n = 21) | Psychogenic non-epileptic seizures (n = 9) | Definite epilepsy (n = 15) | No seizure disorder (n = 341) | All (n = 380) | |
|---|---|---|---|---|---|
| Demographics | |||||
| Age (Mean (SD)) | 41 (14) | 30 (11) | 46 (18) | 40 (16) | 39 (15) |
| Female sex (N (%)) | 6 (28.6%) | 8 (88.9%) | 4 (26.7%) | 167 (49.0%) | 184 (48.4%) |
| Educational status | N (%) | N (%) | N (%) | N (%) | N (%) |
| Not completed secondary school | 0% | 0% | 0% | 0% | 0% |
| Secondary school | 13 (61.9%) | 4 (44.4%) | 4 (26.7%) | 147 (43.1%) | 166 (43.7%) |
| High school | 8 (38.1%) | 4 (44.4%) | 8 (53.3%) | 145 (42.5%) | 161 (42.4%) |
| Bachelor | 0% | 1 (11.1%) | 3 (20.0%) | 40 (11.7%) | 44 (11.6%) |
| Master | 0% | 0% | 0% | 7 (2.1%) | 7 (1.8%) |
| Ph. D. | 0% | 0% | 0% | 2 (0.6%) | 2 (0.5%) |
| Main diagnosis on admission | N (%) | N (%) | N (%) | N (%) | N (%) |
| F00-09 Organic psychiatric disorder | 0% | 0% | 2 (13.3%) | 16 (4.7%) | 18 (4.7%) |
| F10-19 Disorders related to psychoactive substance use | 11 (52.4%) | 2 (22.2%) | 4 (26.7%) | 67 (19.6%) | 80 (21.1%) |
| F20-29 Schizophrenia and other psychotic disorders | 1 (4.8%) | 1 (11.1%) | 0% | 49 (14.4%) | 51 (13.4%) |
| F30-31 Bipolar mood disorder | 2 (9.5%) | 0% | 3 (20.0%) | 51 (15.0%) | 56 (14.7%) |
| F32-39 Other mood disorder | 2 (9.5%) | 1 (11.1%) | 2 (13.3%) | 72 (21.1%) | 77 (20.3%) |
| F40-99 Other psychiatric disorders | 4 (19.0%) | 5 (55.6%) | 2 (13.3%) | 74 (21.7%) | 84 (22.1%) |
| Not psychiatric main diagnosis | 1 (4.8%) | 0% | 2 (13.3%) | 12 (3.5%) | 14 (3.7%) |
| Substance usea | N (%) | N (%) | N (%) | N (%) | N (%) |
| Benzodiazepines | 15 (71.4%) | 5 (55.6%) | 11 (73.3%) | 148 (43.3%) | 172 (45.3%) |
| Stimulants | 8 (38.1%) | 2 (22.2%) | 2 (13.3%) | 73 (21.4%) | 82 (21.6%) |
| Cannabis | 6 (28.6%) | 0% | 3 (20.0%) | 77 (22.6%) | 85 (22.4%) |
| Alcohol | 13 (61.9%) | 2 (22.2%) | 3 (20.0%) | 125 (36.7%) | 140 (36.8%) |
| Opioids | 4 (19.0%) | 3 (33.3%) | 2 (13.3%) | 56 (16.4%) | 63 (16.6%) |
| Medicationsb | N (%) | N (%) | N (%) | N (%) | N (%) |
| Anti-seizure medications | 5 (23.8%) | 2 (22.2%) | 8 (53.3%) | 35 (10.3%) | 48 (12.6%) |
| Antipsychotics | 7 (33.3%) | 2 (22.2%) | 7 (46.7%) | 105 (30.8%) | 118 (31.1%) |
| Antihistamines | 3 (14.3%) | 4 (44.4%) | 2 (13.3%) | 45 (13.2%) | 54 (14.2%) |
| Antidepressants | 7 (33.3%) | 5 (55.6%) | 5 (33.3%) | 89 (26.1%) | 103 (27.1%) |
| Lithium | 0% | 0% | 1 (6.7%) | 11 (3.2%) | 12 (3.2%) |
| Stimulants | 1 (4.8%) | 1 (11.1%) | 0% | 6 (1.8%) | 8 (2.1%) |
| Benzodiazepines | 8 (38.1%) | 5 (55.6%) | 6 (40.0%) | 75 (22.0%) | 89 (23.4%) |
| Z-hypnotics | 5 (23.8%) | 2 (22.2%) | 5 (33.3%) | 58 (17.0%) | 68 (17.9%) |
| Opioids | 2 (9.5%) | 1 (11.1%) | 0% | 16 (4.7%) | 19 (5.0%) |